{"id":"W2088951542","doi":"10.1158/1538-7445.am10-lb-171","title":"Abstract LB-171: A phase 1 dose escalation study of BBI608, a first-in-class cancer stem cell pathway inhibitor in patients with advanced malignancies","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Cancer; Cancer stem cell; Discontinuation; Adverse effect; Internal medicine; Oncology; Stem cell; Pharmacology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001182751,0.00136767,0.001889456,0.0006876093,0.0004204127,0.0008963144,0.000769272,0.001029157,0.003444302],"category_scores_gemma":[0.0006000918,0.0006087379,0.0009487871,0.0004834141,0.0007007652,0.0006911083,0.0003544681,0.004075232,0.001071875],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000949811,"about_ca_system_score_gemma":0.001450425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007991955,"about_ca_topic_score_gemma":0.00175641,"domain_scores_codex":[0.9996142,0.0001386209,0.00002355837,0.00006966794,0.00006136189,0.0000925321],"domain_scores_gemma":[0.9995881,0.00005497448,0.00006693906,0.00003597089,0.00004124614,0.0002127841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3368563,0.1774493,0.008486768,0.001603811,0.00153309,0.0005524122,0.0006263282,0.005489043,0.2616266,0.0007462091,0.01159198,0.1934381],"study_design_scores_gemma":[0.2773325,0.6825944,0.01351698,0.00004813297,0.0005049002,0.0004856203,0.0000760277,0.002060704,0.01743038,0.0002987329,0.005594724,0.00005701581],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885036,0.002661018,0.001017801,0.000551542,0.0001422095,0.002833577,0.001263829,0.000252752,0.002773698],"genre_scores_gemma":[0.9857118,0.001677004,0.002757749,0.0009730888,0.0001543075,0.002292311,0.002691565,0.00005002752,0.003692138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003444302,"threshold_uncertainty_score":0.01152235,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04148746656592465,"score_gpt":0.3647758183299043,"score_spread":0.3232883517639796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}